(opens in a new window)InSphero is a leading supplier of organotypic, biological microtissues for biomimetic drug testing. The company collaborates with more than ten global pharma companies to implement the company’s proprietary microtissue technology. InSphero is a spin-off company of the ETH Zürich and the University Zürich and was founded in 2009 by Dr. Jan Lichtenberg, Dr. Jens M. Kelm and Dr. W. Moritz. InSphero was recognised for its achievements with the VentureKick Award, the Heuberger Entrepreneurial Award, InSphero won the ACES Award as Top European Academic Enterprise in Life Sciences 2014 and was ranked the #1 Swiss Startup in 2014. InSphero pioneered the use of organotypic microtissue-based assays to screen biochemical compounds for efficacy and safety.
Project Participants:
Wolfgang Moritz, Head of Research and Applications